The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Tag Archives: Critical Path Initiative

Personalized Medicine: First SAEC Data

The FDA (as part of the Critical Path Initiative) and the International Serious Adverse Event Consortium (SAECannounced the release of their first data on the genetic basis of adverse drug reactions today.
Read more of this post

Follow

Get every new post delivered to your Inbox.

Join 129 other followers